#medrxiv — Public Fediverse posts

#OpenRxiv just added an #AI #PeerReview feature for #preprints on #bioRxiv and #medRxiv. At the moment, they're using the #qedscience tool.
https://www.nature.com/articles/d41586-025-03909-5

The bioRxiv announcement makes clear that AI review is optional for authors and that authors might be able to choose from other AI tools in the future.
https://connect.biorxiv.org/news/2025/11/04/qed_review_tool

PS: My experiments lead me to think that AI isn't good enough to do peer review yet -- even if (1) it's getting better, (2) it can already help human reviewers, and (3) many human reviewers are worse. Journals that allow it too large a role are abdicating their responsibility and might be deceiving authors and readers. Referees who give it too large a role are abdicating their responsibility and might be deceiving journals, authors, and readers. If you lean in the same direction, let me suggest that these objections don't carry over to preprint servers making AI review an #FWIW option for authors. This kind of AI review doesn't pretend to be more than it is. When it happens, it's a voluntary decision by authors. Of course authors could have gotten AI feedback on their own, with the AI tools of their choice, and without the preprint-server mediation. But giving them another option for the same kind of feedback is harmless and convenient. Moreover, it creates a training ground to monitor the quality and improvement of the AI tools.

#OpenRxiv just added an #AI #PeerReview feature for #preprints on #bioRxiv and #medRxiv. At the moment, they're using the #qedscience tool.
https://www.nature.com/articles/d41586-025-03909-5

The bioRxiv announcement makes clear that AI review is optional for authors and that authors might be able to choose from other AI tools in the future.
https://connect.biorxiv.org/news/2025/11/04/qed_review_tool

PS: My experiments lead me to think that AI isn't good enough to do peer review yet -- even if (1) it's getting better, (2) it can already help human reviewers, and (3) many human reviewers are worse. Journals that allow it too large a role are abdicating their responsibility and might be deceiving authors and readers. Referees who give it too large a role are abdicating their responsibility and might be deceiving journals, authors, and readers. If you lean in the same direction, let me suggest that these objections don't carry over to preprint servers making AI review an #FWIW option for authors. This kind of AI review doesn't pretend to be more than it is. When it happens, it's a voluntary decision by authors. Of course authors could have gotten AI feedback on their own, with the AI tools of their choice, and without the preprint-server mediation. But giving them another option for the same kind of feedback is harmless and convenient. Moreover, it creates a training ground to monitor the quality and improvement of the AI tools.

#OpenRxiv just added an #AI #PeerReview feature for #preprints on #bioRxiv and #medRxiv. At the moment, they're using the #qedscience tool.
https://www.nature.com/articles/d41586-025-03909-5

The bioRxiv announcement makes clear that AI review is optional for authors and that authors might be able to choose from other AI tools in the future.
https://connect.biorxiv.org/news/2025/11/04/qed_review_tool

PS: My experiments lead me to think that AI isn't good enough to do peer review yet -- even if (1) it's getting better, (2) it can already help human reviewers, and (3) many human reviewers are worse. Journals that allow it too large a role are abdicating their responsibility and might be deceiving authors and readers. Referees who give it too large a role are abdicating their responsibility and might be deceiving journals, authors, and readers. If you lean in the same direction, let me suggest that these objections don't carry over to preprint servers making AI review an #FWIW option for authors. This kind of AI review doesn't pretend to be more than it is. When it happens, it's a voluntary decision by authors. Of course authors could have gotten AI feedback on their own, with the AI tools of their choice, and without the preprint-server mediation. But giving them another option for the same kind of feedback is harmless and convenient. Moreover, it creates a training ground to monitor the quality and improvement of the AI tools.

#OpenRxiv just added an #AI #PeerReview feature for #preprints on #bioRxiv and #medRxiv. At the moment, they're using the #qedscience tool.
https://www.nature.com/articles/d41586-025-03909-5

The bioRxiv announcement makes clear that AI review is optional for authors and that authors might be able to choose from other AI tools in the future.
https://connect.biorxiv.org/news/2025/11/04/qed_review_tool

PS: My experiments lead me to think that AI isn't good enough to do peer review yet -- even if (1) it's getting better, (2) it can already help human reviewers, and (3) many human reviewers are worse. Journals that allow it too large a role are abdicating their responsibility and might be deceiving authors and readers. Referees who give it too large a role are abdicating their responsibility and might be deceiving journals, authors, and readers. If you lean in the same direction, let me suggest that these objections don't carry over to preprint servers making AI review an #FWIW option for authors. This kind of AI review doesn't pretend to be more than it is. When it happens, it's a voluntary decision by authors. Of course authors could have gotten AI feedback on their own, with the AI tools of their choice, and without the preprint-server mediation. But giving them another option for the same kind of feedback is harmless and convenient. Moreover, it creates a training ground to monitor the quality and improvement of the AI tools.

#OpenRxiv just added an #AI #PeerReview feature for #preprints on #bioRxiv and #medRxiv. At the moment, they're using the #qedscience tool.
https://www.nature.com/articles/d41586-025-03909-5

The bioRxiv announcement makes clear that AI review is optional for authors and that authors might be able to choose from other AI tools in the future.
https://connect.biorxiv.org/news/2025/11/04/qed_review_tool

PS: My experiments lead me to think that AI isn't good enough to do peer review yet -- even if (1) it's getting better, (2) it can already help human reviewers, and (3) many human reviewers are worse. Journals that allow it too large a role are abdicating their responsibility and might be deceiving authors and readers. Referees who give it too large a role are abdicating their responsibility and might be deceiving journals, authors, and readers. If you lean in the same direction, let me suggest that these objections don't carry over to preprint servers making AI review an #FWIW option for authors. This kind of AI review doesn't pretend to be more than it is. When it happens, it's a voluntary decision by authors. Of course authors could have gotten AI feedback on their own, with the AI tools of their choice, and without the preprint-server mediation. But giving them another option for the same kind of feedback is harmless and convenient. Moreover, it creates a training ground to monitor the quality and improvement of the AI tools.

Neue Studie zeigt: IgG-Antikörper von ME/CFS-Patientinnen und Patienten dringen gezielt in Endothelzellen ein, verbleiben länger als bei Gesunden und verursachen Zellschäden. Das stützt die Idee, dass Autoantikörper direkte Krankheitsfaktoren sind und Gefäßfunktionen sowie Mikrozirkulation beeinträchtigen – ein möglicher Schlüssel für neue Diagnostik und Therapie.

Übersetzung und Zusammenfassung auf: https://www.fatigatio.de/aktuelles/detail/zusammenfassung-studie-vergleichende-analyse-des-eindringens-von-igg-aus-me-cfs-patienten-in-menschliche-endothelzellen

#MECFS #medrxiv #Preprint #Endothelzellen #MECFSFachtagung

1/2

Neue Studie zeigt: IgG-Antikörper von ME/CFS-Patientinnen und Patienten dringen gezielt in Endothelzellen ein, verbleiben länger als bei Gesunden und verursachen Zellschäden. Das stützt die Idee, dass Autoantikörper direkte Krankheitsfaktoren sind und Gefäßfunktionen sowie Mikrozirkulation beeinträchtigen – ein möglicher Schlüssel für neue Diagnostik und Therapie.

Übersetzung und Zusammenfassung auf: https://www.fatigatio.de/aktuelles/detail/zusammenfassung-studie-vergleichende-analyse-des-eindringens-von-igg-aus-me-cfs-patienten-in-menschliche-endothelzellen

#MECFS #medrxiv #Preprint #Endothelzellen #MECFSFachtagung

1/2

Neue Studie zeigt: IgG-Antikörper von ME/CFS-Patientinnen und Patienten dringen gezielt in Endothelzellen ein, verbleiben länger als bei Gesunden und verursachen Zellschäden. Das stützt die Idee, dass Autoantikörper direkte Krankheitsfaktoren sind und Gefäßfunktionen sowie Mikrozirkulation beeinträchtigen – ein möglicher Schlüssel für neue Diagnostik und Therapie.

Übersetzung und Zusammenfassung auf: https://www.fatigatio.de/aktuelles/detail/zusammenfassung-studie-vergleichende-analyse-des-eindringens-von-igg-aus-me-cfs-patienten-in-menschliche-endothelzellen

#MECFS #medrxiv #Preprint #Endothelzellen #MECFSFachtagung

1/2

Neue Studie zeigt: IgG-Antikörper von ME/CFS-Patientinnen und Patienten dringen gezielt in Endothelzellen ein, verbleiben länger als bei Gesunden und verursachen Zellschäden. Das stützt die Idee, dass Autoantikörper direkte Krankheitsfaktoren sind und Gefäßfunktionen sowie Mikrozirkulation beeinträchtigen – ein möglicher Schlüssel für neue Diagnostik und Therapie.

Übersetzung und Zusammenfassung auf: https://www.fatigatio.de/aktuelles/detail/zusammenfassung-studie-vergleichende-analyse-des-eindringens-von-igg-aus-me-cfs-patienten-in-menschliche-endothelzellen

#MECFS #medrxiv #Preprint #Endothelzellen #MECFSFachtagung

1/2

Boys with Noonan Syndrome at the 97%ile for BMI will collapse into a singularity at ~17.5 years age. It's very sad. In other news, learned in 2 days how to use #Rlang #quarto-preprint with #typst to submit a report on corrected LMS growth curve parameters to #MedRxiv doi:10.1101/2025.07.29.25332354

Boys with Noonan Syndrome at the 97%ile for BMI will collapse into a singularity at ~17.5 years age. It's very sad. In other news, learned in 2 days how to use #Rlang #quarto-preprint with #typst to submit a report on corrected LMS growth curve parameters to #MedRxiv doi:10.1101/2025.07.29.25332354

Boys with Noonan Syndrome at the 97%ile for BMI will collapse into a singularity at ~17.5 years age. It's very sad. In other news, learned in 2 days how to use #Rlang #quarto-preprint with #typst to submit a report on corrected LMS growth curve parameters to #MedRxiv doi:10.1101/2025.07.29.25332354

Light exposure at night predicts incidence of cardiovascular diseases

https://www.medrxiv.org/content/10.1101/2025.06.20.25329961v1

#HackerNews #LightExposure #NightHealth #CardiovascularResearch #SleepScience #MedRxiv

Light exposure at night predicts incidence of cardiovascular diseases

https://www.medrxiv.org/content/10.1101/2025.06.20.25329961v1

#HackerNews #LightExposure #NightHealth #CardiovascularResearch #SleepScience #MedRxiv

Light exposure at night predicts incidence of cardiovascular diseases

https://www.medrxiv.org/content/10.1101/2025.06.20.25329961v1

#HackerNews #LightExposure #NightHealth #CardiovascularResearch #SleepScience #MedRxiv

Light exposure at night predicts incidence of cardiovascular diseases

https://www.medrxiv.org/content/10.1101/2025.06.20.25329961v1

#HackerNews #LightExposure #NightHealth #CardiovascularResearch #SleepScience #MedRxiv

Light exposure at night predicts incidence of cardiovascular diseases

https://www.medrxiv.org/content/10.1101/2025.06.20.25329961v1

#HackerNews #LightExposure #NightHealth #CardiovascularResearch #SleepScience #MedRxiv

Semantic search engine for ArXiv, biorxiv and medrxiv

https://arxivxplorer.com/

#HackerNews #SemanticSearch #ArXiv #Biorxiv #Medrxiv #ResearchTools

Semantic search engine for ArXiv, biorxiv and medrxiv

https://arxivxplorer.com/

#HackerNews #SemanticSearch #ArXiv #Biorxiv #Medrxiv #ResearchTools

Semantic search engine for ArXiv, biorxiv and medrxiv

https://arxivxplorer.com/

#HackerNews #SemanticSearch #ArXiv #Biorxiv #Medrxiv #ResearchTools

Semantic search engine for ArXiv, biorxiv and medrxiv

https://arxivxplorer.com/

#HackerNews #SemanticSearch #ArXiv #Biorxiv #Medrxiv #ResearchTools

In the updated license selector, the most open Creative Commons licenses appear first, with refreshed accessible language for each license that centers the researcher and their choices. Thanks to the Chan Zuckerberg Initiative for supporting these efforts.

#OpenScience #Preprints #CreativeCommons #bioRxiv #medRxiv #OpenAccess #Research #openRxiv

In the updated license selector, the most open Creative Commons licenses appear first, with refreshed accessible language for each license that centers the researcher and their choices. Thanks to the Chan Zuckerberg Initiative for supporting these efforts.

#OpenScience #Preprints #CreativeCommons #bioRxiv #medRxiv #OpenAccess #Research #openRxiv

In the updated license selector, the most open Creative Commons licenses appear first, with refreshed accessible language for each license that centers the researcher and their choices. Thanks to the Chan Zuckerberg Initiative for supporting these efforts.

#OpenScience #Preprints #CreativeCommons #bioRxiv #medRxiv #OpenAccess #Research #openRxiv

In the updated license selector, the most open Creative Commons licenses appear first, with refreshed accessible language for each license that centers the researcher and their choices. Thanks to the Chan Zuckerberg Initiative for supporting these efforts.

#OpenScience #Preprints #CreativeCommons #bioRxiv #medRxiv #OpenAccess #Research #openRxiv

In the updated license selector, the most open Creative Commons licenses appear first, with refreshed accessible language for each license that centers the researcher and their choices. Thanks to the Chan Zuckerberg Initiative for supporting these efforts.

#OpenScience #Preprints #CreativeCommons #bioRxiv #medRxiv #OpenAccess #Research #openRxiv

internationalen Cochrane‑Reviews, Publikationen in renommierten Fachzeitschriften wie #Nature und The #Lancet sowie aus Datenbanken wie #medRxiv und #PubMed – belegen, dass die #Qualität der #Innenraumluft einen zentralen Einfluss auf die Übertragungswege von Aerosol‑ und Tröpfchenviren besitzt.

internationalen Cochrane‑Reviews, Publikationen in renommierten Fachzeitschriften wie #Nature und The #Lancet sowie aus Datenbanken wie #medRxiv und #PubMed – belegen, dass die #Qualität der #Innenraumluft einen zentralen Einfluss auf die Übertragungswege von Aerosol‑ und Tröpfchenviren besitzt.

internationalen Cochrane‑Reviews, Publikationen in renommierten Fachzeitschriften wie #Nature und The #Lancet sowie aus Datenbanken wie #medRxiv und #PubMed – belegen, dass die #Qualität der #Innenraumluft einen zentralen Einfluss auf die Übertragungswege von Aerosol‑ und Tröpfchenviren besitzt.

internationalen Cochrane‑Reviews, Publikationen in renommierten Fachzeitschriften wie #Nature und The #Lancet sowie aus Datenbanken wie #medRxiv und #PubMed – belegen, dass die #Qualität der #Innenraumluft einen zentralen Einfluss auf die Übertragungswege von Aerosol‑ und Tröpfchenviren besitzt.

internationalen Cochrane‑Reviews, Publikationen in renommierten Fachzeitschriften wie #Nature und The #Lancet sowie aus Datenbanken wie #medRxiv und #PubMed – belegen, dass die #Qualität der #Innenraumluft einen zentralen Einfluss auf die Übertragungswege von Aerosol‑ und Tröpfchenviren besitzt.

Prépublications en sciences de la vie et de la santé : #bioRxiv et #medRxiv lancent #openRxiv une organisation indépendante à but non lucratif chargée de leur gouvernance
#Preprints #OpenAccess

https://www.nature.com/articles/d41586-025-00762-4

Prépublications en sciences de la vie et de la santé : #bioRxiv et #medRxiv lancent #openRxiv une organisation indépendante à but non lucratif chargée de leur gouvernance
#Preprints #OpenAccess

https://www.nature.com/articles/d41586-025-00762-4

Prépublications en sciences de la vie et de la santé : #bioRxiv et #medRxiv lancent #openRxiv une organisation indépendante à but non lucratif chargée de leur gouvernance
#Preprints #OpenAccess

https://www.nature.com/articles/d41586-025-00762-4

Prépublications en sciences de la vie et de la santé : #bioRxiv et #medRxiv lancent #openRxiv une organisation indépendante à but non lucratif chargée de leur gouvernance
#Preprints #OpenAccess

https://www.nature.com/articles/d41586-025-00762-4

#Preprint sites #bioRxiv and #medRxiv launch new era of independence
The popular repositories, where life #scientists post research before #peerreview, will be managed by a new organization called #openRxiv.
Until now, they had been managed by Cold Spring Harbor Laboratory. The new organization, named openRxiv, will have a board of directors and a scientific and medical advisory board. It is supported by a fresh US$16M grant from Chan Zuckerberg Initiative (CZI).
https://www.nature.com/articles/d41586-025-00762-4

#Preprint sites #bioRxiv and #medRxiv launch new era of independence
The popular repositories, where life #scientists post research before #peerreview, will be managed by a new organization called #openRxiv.
Until now, they had been managed by Cold Spring Harbor Laboratory. The new organization, named openRxiv, will have a board of directors and a scientific and medical advisory board. It is supported by a fresh US$16M grant from Chan Zuckerberg Initiative (CZI).
https://www.nature.com/articles/d41586-025-00762-4

#Preprint sites #bioRxiv and #medRxiv launch new era of independence
The popular repositories, where life #scientists post research before #peerreview, will be managed by a new organization called #openRxiv.
Until now, they had been managed by Cold Spring Harbor Laboratory. The new organization, named openRxiv, will have a board of directors and a scientific and medical advisory board. It is supported by a fresh US$16M grant from Chan Zuckerberg Initiative (CZI).
https://www.nature.com/articles/d41586-025-00762-4

#Preprint sites #bioRxiv and #medRxiv launch new era of independence
The popular repositories, where life #scientists post research before #peerreview, will be managed by a new organization called #openRxiv.
Until now, they had been managed by Cold Spring Harbor Laboratory. The new organization, named openRxiv, will have a board of directors and a scientific and medical advisory board. It is supported by a fresh US$16M grant from Chan Zuckerberg Initiative (CZI).
https://www.nature.com/articles/d41586-025-00762-4

#Preprint sites #bioRxiv and #medRxiv launch new era of independence
The popular repositories, where life #scientists post research before #peerreview, will be managed by a new organization called #openRxiv.
Until now, they had been managed by Cold Spring Harbor Laboratory. The new organization, named openRxiv, will have a board of directors and a scientific and medical advisory board. It is supported by a fresh US$16M grant from Chan Zuckerberg Initiative (CZI).
https://www.nature.com/articles/d41586-025-00762-4

Precisely, the STEM community got it right with #arxiV , time for the rest of us to get on board with #medrxiV and #biorxiV. This will also save a lot of money from frivolous publication activities that only enrich the publishers but deprive everyone else of the benefits of publicly funded research

RE: https://bsky.app/profile/did:plc:7t2iueljk2bzxf6d2rcdhg7r/post/3licpt7lurs2q

Ugwu et al. medRxiv August 20, 2024

Risk Factors of Human Mpox (Monkeypox) Infection: A Systematic Review and Meta-Analysis

"...interaction with infected animals, HIV, other STIs, sexual contact/activities, contact with an infected person, MSM, and having multiple sexual partners, were associated with an increased risk of contracting Mpox."
"...patients who were vaccinated against smallpox had a lower risk of Mpox infection"

https://www.medrxiv.org/content/10.1101/2024.08.14.24311975v1

#Mpox #infection #RiskFactors #medRxiv

Ugwu et al. medRxiv August 20, 2024

Risk Factors of Human Mpox (Monkeypox) Infection: A Systematic Review and Meta-Analysis

"...interaction with infected animals, HIV, other STIs, sexual contact/activities, contact with an infected person, MSM, and having multiple sexual partners, were associated with an increased risk of contracting Mpox."
"...patients who were vaccinated against smallpox had a lower risk of Mpox infection"

https://www.medrxiv.org/content/10.1101/2024.08.14.24311975v1

#Mpox #infection #RiskFactors #medRxiv

Ugwu et al. medRxiv August 20, 2024

Risk Factors of Human Mpox (Monkeypox) Infection: A Systematic Review and Meta-Analysis

"...interaction with infected animals, HIV, other STIs, sexual contact/activities, contact with an infected person, MSM, and having multiple sexual partners, were associated with an increased risk of contracting Mpox."
"...patients who were vaccinated against smallpox had a lower risk of Mpox infection"

https://www.medrxiv.org/content/10.1101/2024.08.14.24311975v1

#Mpox #infection #RiskFactors #medRxiv

New study: Given the publishing requirements for medical professors in #India, and given the number of future medical professors in the pipeline, it's possible to calculate that Indian medical journals cannot meet the expected author-side demand. "Thus there is a need to have a national medical #repository such as #MedRxiv to prevent publication in #predatory journals."
https://nmji.in/publication-requirement-for-faculty-promotion-in-medical-institutions-in-india-mind-the-gap/

#GreenOA #Medicine #Preprints #ScholComm

New study: Given the publishing requirements for medical professors in #India, and given the number of future medical professors in the pipeline, it's possible to calculate that Indian medical journals cannot meet the expected author-side demand. "Thus there is a need to have a national medical #repository such as #MedRxiv to prevent publication in #predatory journals."
https://nmji.in/publication-requirement-for-faculty-promotion-in-medical-institutions-in-india-mind-the-gap/

#GreenOA #Medicine #Preprints #ScholComm

New study: Given the publishing requirements for medical professors in #India, and given the number of future medical professors in the pipeline, it's possible to calculate that Indian medical journals cannot meet the expected author-side demand. "Thus there is a need to have a national medical #repository such as #MedRxiv to prevent publication in #predatory journals."
https://nmji.in/publication-requirement-for-faculty-promotion-in-medical-institutions-in-india-mind-the-gap/

#GreenOA #Medicine #Preprints #ScholComm

New study: Given the publishing requirements for medical professors in #India, and given the number of future medical professors in the pipeline, it's possible to calculate that Indian medical journals cannot meet the expected author-side demand. "Thus there is a need to have a national medical #repository such as #MedRxiv to prevent publication in #predatory journals."
https://nmji.in/publication-requirement-for-faculty-promotion-in-medical-institutions-in-india-mind-the-gap/

#GreenOA #Medicine #Preprints #ScholComm

New study: Given the publishing requirements for medical professors in #India, and given the number of future medical professors in the pipeline, it's possible to calculate that Indian medical journals cannot meet the expected author-side demand. "Thus there is a need to have a national medical #repository such as #MedRxiv to prevent publication in #predatory journals."
https://nmji.in/publication-requirement-for-faculty-promotion-in-medical-institutions-in-india-mind-the-gap/

#GreenOA #Medicine #Preprints #ScholComm

bioRxiv just turned 10 years old and medRxiv is now 4! 🎉 If you are a preprint reader and/or author, please fill out the bioRxiv & medRxiv survey now!
https://bit.ly/biomedrxivsurvey
Deadline: December 10th, 11:59 PM EST
Length: 15-20 mins
Thank you!
#biorxiv #medrxiv #preprints

bioRxiv just turned 10 years old and medRxiv is now 4! 🎉 If you are a preprint reader and/or author, please fill out the bioRxiv & medRxiv survey now!
https://bit.ly/biomedrxivsurvey
Deadline: December 10th, 11:59 PM EST
Length: 15-20 mins
Thank you!
#biorxiv #medrxiv #preprints

bioRxiv just turned 10 years old and medRxiv is now 4! 🎉 If you are a preprint reader and/or author, please fill out the bioRxiv & medRxiv survey now!
https://bit.ly/biomedrxivsurvey
Deadline: December 10th, 11:59 PM EST
Length: 15-20 mins
Thank you!
#biorxiv #medrxiv #preprints

bioRxiv just turned 10 years old and medRxiv is now 4! 🎉 If you are a preprint reader and/or author, please fill out the bioRxiv & medRxiv survey now!
https://bit.ly/biomedrxivsurvey
Deadline: December 10th, 11:59 PM EST
Length: 15-20 mins
Thank you!
#biorxiv #medrxiv #preprints

bioRxiv just turned 10 years old and medRxiv is now 4! 🎉 If you are a preprint reader and/or author, please fill out the bioRxiv & medRxiv survey now!
https://bit.ly/biomedrxivsurvey
Deadline: December 10th, 11:59 PM EST
Length: 15-20 mins
Thank you!
#biorxiv #medrxiv #preprints

bioRxiv is almost 10 years old and medRxiv just turned 4! 🎉 Tell us how we’ve done so far & how to keep improving by answering the bioRxiv & medRxiv survey!
Deadline: December 10th, 11:59 PM EST
Length: 15-20 mins
Thank you!
🔗 https://bit.ly/biomedrxivsurvey
#biorxivmedrxivsurvey #biorxiv #medrxiv #preprints

bioRxiv is almost 10 years old and medRxiv just turned 4! 🎉 Tell us how we’ve done so far & how to keep improving by answering the bioRxiv & medRxiv survey!
Deadline: December 10th, 11:59 PM EST
Length: 15-20 mins
Thank you!
🔗 https://bit.ly/biomedrxivsurvey
#biorxivmedrxivsurvey #biorxiv #medrxiv #preprints

bioRxiv is almost 10 years old and medRxiv just turned 4! 🎉 Tell us how we’ve done so far & how to keep improving by answering the bioRxiv & medRxiv survey!
Deadline: December 10th, 11:59 PM EST
Length: 15-20 mins
Thank you!
🔗 https://bit.ly/biomedrxivsurvey
#biorxivmedrxivsurvey #biorxiv #medrxiv #preprints

bioRxiv is almost 10 years old and medRxiv just turned 4! 🎉 Tell us how we’ve done so far & how to keep improving by answering the bioRxiv & medRxiv survey!
Deadline: December 10th, 11:59 PM EST
Length: 15-20 mins
Thank you!
🔗 https://bit.ly/biomedrxivsurvey
#biorxivmedrxivsurvey #biorxiv #medrxiv #preprints

bioRxiv is almost 10 years old and medRxiv just turned 4! 🎉 Tell us how we’ve done so far & how to keep improving by answering the bioRxiv & medRxiv survey!
Deadline: December 10th, 11:59 PM EST
Length: 15-20 mins
Thank you!
🔗 https://bit.ly/biomedrxivsurvey
#biorxivmedrxivsurvey #biorxiv #medrxiv #preprints

@steveroyle Done!
IMHO it would be nice if @biorxivpreprint and @medrxivpreprint would accept theoretical / conceptual preprints (as far as I know they are rejected on screening, unless it changed recently). So I made that suggestion on the survey.

#biorxiv #medrxiv #biology #science #research #academicchater